Cargando…
Learning from history: do not flatten the curve of antiviral research!
Here, we explore the dynamics of the response of the scientific community to several epidemics, including Coronavirus Disease 2019 (COVID-19), as assessed by the numbers of clinical trials, publications, and level of research funding over time. All six prior epidemics studied [bird flu, severe acute...
Autores principales: | Bobrowski, Tesia, Melo-Filho, Cleber C., Korn, Daniel, Alves, Vinicius M., Popov, Konstantin I., Auerbach, Scott, Schmitt, Charles, Moorman, Nathaniel J., Muratov, Eugene N., Tropsha, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361119/ https://www.ncbi.nlm.nih.gov/pubmed/32679173 http://dx.doi.org/10.1016/j.drudis.2020.07.008 |
Ejemplares similares
-
Conserved coronavirus proteins as targets of broad-spectrum antivirals
por: Melo-Filho, Cleber C., et al.
Publicado: (2022) -
Computational models identify several FDA approved or experimental drugs as putative agents against SARS-CoV-2
por: Bobrowski, Tesia, et al.
Publicado: (2020) -
COVID-19 Knowledge Extractor (COKE): a tool and a web portal to extract drug - target protein associations from the CORD-19 corpus of scientific publications on COVID-19
por: Korn, Daniel, et al.
Publicado: (2020) -
Small Molecule Antiviral Compound Collection (SMACC): a database to support the discovery of broad-spectrum antiviral drug molecules
por: Martin, Holli-Joi, et al.
Publicado: (2022) -
COVID-KOP: Integrating Emerging COVID-19 Data with the ROBOKOP Database
por: Korn, Daniel, et al.
Publicado: (2020)